Evaluation of Parenteral Nutrition–Associated Liver Disease in Infants With Necrotizing Enterocolitis Before and After the Implementation of Feeding Guidelines

Abstract

Background: In 2009, an intestinal rehabilitation team implemented feeding guidelines for infants following gastrointestinal surgery at our institution. The purpose of this study was to determine the effect of enteral feeding guidelines on the incidence of parenteral nutrition (PN)–associated liver disease (PNALD) in infants with surgically managed necrotizing enterocolitis (NEC). Methods: This retrospective study included infants treated during 18-month time periods before and after the implementation of feeding guidelines. PNALD diagnosis was based on serum direct bilirubin >2 mg/dL after ≥14 days of PN exposure. Results: Of the 140 infants identified, 64 were surgically managed and included in the analysis. The duration of PN and the time nil per os (NPO) were significantly reduced after guideline implementation from a median of 106 days to 65 days (P = .03) and from 29 days to 16 days (P = .02), respectively. The incidence of PNALD decreased from 73% before guideline implementation to 42% after guideline implementation (P = .01). Conclusions: Implementation of feeding guidelines resulted in decreased time NPO and duration of PN support. Significantly fewer infants developed PNALD after guideline implementation. These data suggest that feeding guidelines may expedite the transition from PN to enteral nutrition and may improve outcomes.

Keywords

parenteral nutrition enteral nutrition necrotizing enterocolitis short bowel syndrome

Get full access to this article

View all access options for this article.

References

Btaiche

Khalidi

. Parenteral nutrition-associated liver complications in children. Pharmacotherapy. 2002;22:188-211.

Buchman

. Total parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2002;26:S43-S48.

Beath

Davies

Papadopolou

. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996;31:604-606.

Goulet

Joly

Corriol

Colomb-Jung

. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009;14(3):256-261.

Andorsky

Lund

Lillihei

. Nutritional and other post-operative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001;139:27-33.

Christensen

Henry

Wiedmeier

Burnett

Lambert

. Identifying patients, on the first day of life, at high-risk for developing parenteral nutrition-associated liver disease. J Perinatol. 2007;27:284-290.

Beale

Nelson

Bucciarelli

Donnelly

Eitzman

. Intra hepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics. 1979;64(3);342-347.

Rossi

Kadamba

Hugosson

De Vol

Habib

Al-Nassar

. Pediatric short bowel syndrome: adaptation after massive small bowel resection. J Pediatr Gastroenterol Nutr. 2007;45:213-221.

Kelly

. Preventing parenteral nutrition liver disease. Early Hum Dev. 2010;86(11):683-687.

10.

Javid

Collier

Richardson

. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants. J Pediatr Surg. 2005;40(6):1015-1018.

11.

Sigalet

Boctor

Robertson

. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009;19(6):348-353.

12.

Sigalet

Boctor

Brindle

Lam

Robertson

. Elements of successful intestinal rehabilitation. J Pediatr Surg. 2011;46(1):150-156.

13.

Cowles

Ventura

Martinez

. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010;45(1):84-87.

14.

Touloukian

Smith

. Normal intestinal length in preterm infants. J Pediatr Surg. 1983;18(6):720-723.

15.

Healy

Campbell

Zaccaria

Baker

. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics. 2008;121(4):703-710.

16.

Goulet

. Short bowel syndrome in pediatric patients. Nutrition. 1998;14:784-787.

17.

Nasr

Avitzur

De Silva

Wales

. The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome. J Pediatr Surg. 2007;42(2):359-362.

18.

Kaufman

Pehlivanova

Fennelly

. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr. 2010;156(4);580-585.